Background
Host Reactions
Degradation
Special Consideration
Regulatory
100

This portion of a stress-strain curve is analyzed to determine the resilience of a material

Elastic Region

100

Though biocompatibility studies typically look out for these cells inflammatory counterparts, tissue engineers generally try and recruit this tissue-building immune cell

M2 Macrophages

100

The erosion process where a polymer reduces in size, but maintains its bulk properties

Surface erosion

100

This is the ratio of non-sterile devices to sterile devices, and used as a regulatory assurance metric for sterility

Sterility assurance level

100

This stage of device development relies on demonstrating a device’s potential to “insiders” as opposed to “outsiders”

Proof of Concept

200

Rather than measuring the force and stress normal to the cross section of the material, this is dependent on the force vector parallel to the cross section of a sample

Shear stress

200

This type of tests analyses the rupture of red blood cells calorimetrically

Hemolysis

200

In general, polymers that are polar are more susceptible to this type of degradation than non-polar ones

Hydrolytic Degradation

200

If your medical device is made up of PTFE, PMMA, and PLGA, you should stay away from this form of sterilization

Radiation sterilization

200

Cordis filed this to the FDA to petition for their combinational device to be evaluated by the CDRH as opposed to CDER

Request for Designation

300

This is the process of a materials integrating itself with bone

Osseointegration

300

This type of clot, abundant in fibrin and platelets, forms in veins as opposed to arteries

Red thrombus

300

This form of hydrolysis typically occurs last and on the surface due the mediator’s size

Enzyme-catalyzed hydrolysis

300

This is the analysis of the size and shape of a device required prior to e-beam sterilization to account for poor penetration depth, shielding, scattering

Dose-mapping

300

To downgrade a device’s approval requirement via the 510(k) process, companies must make the argument that their device is “similar” to other approved devices

Substantially Equivalent

400

Despite its inflammatory-like name, this is the hosts natural response to an implanted biomaterial. Thin, dense, and avascular are all indicators of good biocompatibility

Foreign Body Reaction

400

Highest concentration measured where NO significant response was detected

No-observable adverse effect level (NOAEL)

400

Oxidative Degradation

Gamma radiation, while fantastic for sterilization, poses problems for polymers susceptible to this kind of degradation

400

This is most common form of terminal sterilization

Ethylene oxide

400

At the end of clinical studies, class III devices file for Pre-Market Approval (PMA); Drugs, on the other hand, file THIS

New Drug Application

500

This type of cell study involves complex mixtures of adhesive proteins with or without ones removed, and is a more accurate way to determine adhesion factors in vivo

Depletion study

500

These are three components that activate platelets

Thromboxane, ADP, and thrombin

500

Corrosion

This is the primary degradation process affecting metals

500

This is the 2nd most common form of terminal sterilization

Gamma sterilization

500

To be eligible to test new device on patients for clinical trials, companies must receive THIS through an IRB board

Investigational Device Exemption (IDE)

M
e
n
u